Dosing of incretin pathway drugs
AssigneeClosed Loop Medicine Ltd.
InventorsPaul GOLDSMITH, David Bruce CAMPBELL, Michael CATT, Tom GODEC, Joe COGHLIN
Life of this patent
Estimating the term…
Abstract
A computer implemented method for determining a dosage of semaglutide for administering to a patient for the treatment of obesity includes receiving patient data relating to a patient, wherein the patient data includes patient weight data; processing the patient data with a dosage calculator to determine the dosage of semaglutide for administering to the patient; and administering the dosage.
Claims23
A method for administering a dosage of an incretin pathway drug to a patient for the treatment of obesity, the method comprising:
- receiving patient data relating to a patient, wherein the patient data includes patient weight data;
- processing the patient data including the patient weight data with a dosage calculator to determine the dosage of the incretin pathway drug for administering to the patient;
- and
- administering the determined dosage of the incretin pathway drug to the patient.
A method for treating a patient for obesity, the method comprising:
- receiving patient data relating to the patient, wherein the patient data includes patient weight data;
- processing the patient data including the patient weight data with a dosage calculator to determine an effective dosage of an incretin pathway drug to administer to the patient;
- and
- administering the determined effective dosage of the incretin pathway drug to the patient to treat the patient for obesity.
Dependencies are inferred from the claim text.